Pharmacy, Hospital Universitario de Getafe, Getafe, Spain
Pharmacy, Hospital Universitario de Getafe, Getafe, Spain.
Eur J Hosp Pharm. 2020 Nov;27(6):369-370. doi: 10.1136/ejhpharm-2018-001746. Epub 2019 Feb 20.
Desensitisation protocols allow the continuation of treatment in patients who have presented hypersensitivity reactions. Carboplatin desensitisation solutions are usually prepared in the chemotherapy centralised units of hospital pharmacies and they are diluted under the established concentration limit to guarantee the stability of the preparation. An online survey was sent to hospital pharmacies, inquiring about local desensitisation protocols: reasons for use of desensitisation protocols, the protocols used and the stability given to carboplatin solutions. An important variability among the hospitals in carboplatin desensitisation practice was detected. Six different carboplatin desensitisation protocols were described and discordance with the storage period of the carboplatin solutions was observed. The lack of consensus on which protocol must be followed and data supporting the stability of the diluted product, contribute to distrust of carboplatin desensitisation protocols. Although the efficacy and safety of carboplatin desensitisation protocols has been widely demonstrated, many professionals still have concerns.
脱敏方案允许在出现过敏反应的患者中继续治疗。卡铂脱敏溶液通常在医院药房的化疗集中单元中制备,并在既定浓度限制下稀释,以保证制剂的稳定性。我们向医院药房发送了一份在线调查,询问有关局部脱敏方案的问题:使用脱敏方案的原因、使用的方案以及卡铂溶液的稳定性。我们发现医院之间在卡铂脱敏实践方面存在很大差异。描述了六种不同的卡铂脱敏方案,并观察到卡铂溶液的储存期限不一致。缺乏必须遵循的方案共识以及有关稀释产品稳定性的数据,导致对卡铂脱敏方案的不信任。尽管卡铂脱敏方案的疗效和安全性已得到广泛证明,但许多专业人员仍存在疑虑。